24/7 Market News Snapshot 09 May, 2025 – Rapid Micro Biosystems, Inc. Class A Common Stock (NASDAQ:RPID)

May 9, 2025

DENVER, Colo., 09 May, 2025 (www.247marketnews.com) – (NASDAQ:RPID) are discussed in this article.
Rapid Micro Biosystems, Inc. has exhibited a remarkable performance in the stock market, with shares rising over 21% today, currently trading at $2.971 after opening at $3.00. This surge follows yesterday’s close at $2.450, reflecting increased investor enthusiasm. The trading volume of approximately 526.69K shares highlights significant market activity and optimism surrounding the company’s innovative microbiological quality control solutions.

In a separate announcement, Rapid Micro Biosystems reported impressive first-quarter financial results for 2025, achieving total revenues of $7.2 million, marking a substantial 28% increase from $5.6 million in the same quarter last year. This growth has been fueled by a 64% rise in service revenue, which reached $3.1 million, underscoring the strong demand for the company’s automation solutions aimed at enhancing healthcare product manufacturing efficiency.

CEO Robert Spignesi expressed pride in the company’s accomplishments, stating, “Our significant revenue growth, underpinned by record service revenue, illustrates the effectiveness of our strategic initiatives towards automation and manufacturing efficiency.” The company also reported a remarkable improvement in its gross margin, achieving a 33-percentage point increase year-over-year.

In a strategic move, Rapid Micro Biosystems entered into a global Distribution and Collaboration Agreement with MilliporeSigma, designed to advance the deployment of its flagship Growth Direct® system for microbial quality control testing. Spignesi remarked on the potential of this collaboration to accelerate growth and foster product innovation.

With a positive outlook for 2025, Rapid Micro is projecting revenues of at least $32 million and aims to achieve between 21 to 25 new system placements. The company is well-positioned for continued growth in the life sciences technology sector, with approximately $42 million in cash reserves and no debt, reinforcing its commitment to delivering innovative solutions for safer healthcare products worldwide.

Related news for (RPID)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.